pest
de
petit
rumin
ppr
sever
infecti
diseas
goat
sheep
ppr
viru
pprv
classifi
morbilliviru
famili
paramyxovirida
order
mononegaviral
gibb
et
al
life
cycl
pprv
h
permiss
cell
kumar
et
al
like
morbillivirus
pprv
establish
lymphat
epitheli
tropism
couacyhymann
et
al
hammouchi
et
al
signal
lymphocyt
activ
molecul
slam
member
subset
immunoglobulin
superfamili
exclus
express
immun
cell
epitheli
cell
identifi
receptor
morbillivirus
tatsuo
et
al
tatsuo
et
al
baron
mainli
express
epitheli
tissu
encod
multipl
haplotyp
differ
sheep
breed
around
world
birch
et
al
recent
identifi
epitheli
receptor
measl
viru
mev
canin
distemp
viru
phocin
distemp
viru
pprv
shed
light
mode
entri
virus
muhlebach
et
al
noyc
et
al
pratakpiriya
et
al
melia
et
al
envelop
virus
enter
cell
two
pathway
direct
fusion
receptormedi
endocytosi
major
paramyxovirus
enter
host
cell
via
fusion
viral
envelop
cell
membran
fusion
attribut
interact
domain
f
protein
lead
close
proxim
viral
host
cell
membran
lee
et
al
muhlebach
et
al
howev
shown
previous
mev
enter
vero
cell
express
slam
use
receptormedi
macropinocytosislik
pathway
delpeut
et
al
moreov
recent
studi
demonstr
slam
also
mediat
mev
endocytosi
goncalvescarneiro
et
al
howev
mev
enter
target
cell
via
membran
fusion
cell
surfac
case
process
limit
virus
endocytos
activ
type
interferon
hornung
et
al
anim
virus
enter
host
cell
via
endocyt
pathway
includ
macropinocytosi
phagocytosi
clathrin
caveolaedepend
independ
pathway
sieczkarski
whittak
conner
schmid
pelkman
heleniu
marsh
heleniu
differ
famili
virus
may
util
differ
endocyt
pathway
mercer
heleniu
mercer
et
al
nicola
et
al
major
one
clathrinmedi
endocytosi
use
virus
hepat
c
viru
min
et
al
african
swine
fever
viru
galindo
et
al
dengu
viru
acosta
et
al
singapor
grouper
iridoviru
wang
et
al
human
papillomaviru
type
schelhaa
et
al
simian
hemorrhag
fever
viru
cai
et
al
egg
drop
syndrom
viru
huang
et
al
hantaan
viru
jin
et
al
previou
studi
indic
hiv
use
dynamindepend
endocytosi
celltocel
transmiss
miyauchi
et
al
sloan
et
al
caveolaemedi
endocytosi
second
preval
pathway
use
ebola
viru
simian
viru
japanes
enceph
viru
enter
cell
anderson
et
al
empig
goldsmith
zhu
et
al
accumul
evid
indic
mani
virus
infect
differ
target
cell
via
exist
uptak
pathway
rather
uniqu
mechan
cantin
et
al
cosset
lavillett
rahn
et
al
han
et
al
addit
vaccinia
viru
mercer
heleniu
ebola
viru
nanbo
et
al
saeed
et
al
influenza
viru
de
vri
et
al
rossman
et
al
adenoviru
type
kalin
et
al
picornavirus
echoviru
krieger
et
al
coxsackieviru
b
coyn
et
al
enter
cell
via
macropinocytosi
recent
studi
demonstr
paramyxovirus
includ
nipah
viru
sendai
viru
human
metapneumoviru
human
respiratori
syncyti
viru
newcastl
diseas
viru
mev
cantin
et
al
kolokoltsov
et
al
diederich
et
al
pernet
et
al
schowalt
et
al
goncalvescarneiro
et
al
util
endocyt
machineri
entri
furthermor
viru
entri
may
involv
variou
factor
cell
viru
type
depend
dynamin
cholesterol
nah
exchang
phosphatidylinositol
kinas
acid
ph
nicola
et
al
cantin
et
al
mercer
heleniu
kalin
et
al
zhu
et
al
sloan
et
al
find
suggest
entri
paramyxoviru
pprv
cell
may
use
endocytosi
addit
mechan
present
studi
investig
mechan
entri
pprv
caprin
endometri
epitheli
cell
eec
use
varieti
chemic
inhibitor
rna
interfer
rnai
approach
target
cellular
molecul
involv
pprv
entri
process
data
demonstr
entri
pprv
caprin
eec
occur
via
caveolaemedi
endocytosi
pathway
differ
entri
mechan
caprin
fetal
fibroblast
cell
collect
data
support
idea
addit
direct
fusion
cell
surfac
pprv
may
penetr
cell
endocytosi
least
goat
epitheli
cell
endometri
epitheli
cell
immort
transfect
human
telomeras
revers
transcriptas
confirm
secretori
function
consist
primari
eec
qi
x
et
al
qi
xf
et
al
wang
et
al
kindli
provid
prof
yape
jin
northwest
f
univers
yangl
shaanxi
china
result
immort
portion
eec
prone
age
becam
larger
longer
primari
cell
increas
passag
caprin
fetal
fibroblast
cell
ffc
laboratori
cultur
collect
cultur
dulbecco
minim
essenti
mediumnutri
mixtur
ham
medium
supplement
fetal
bovin
serum
fb
gibco
carlsbad
ca
unit
state
iuml
penicillin
streptomycin
pprv
vaccin
strain
nigeria
also
laboratori
cultur
collect
experiment
materi
autoclav
min
kill
pprv
experi
complet
laboratori
conform
laboratori
requir
experi
complet
laboratori
condit
chlorpromazin
cpz
ammonium
chlorid
chloroquin
dynasor
wortmannin
nystatin
amilorid
eipa
purchas
sigma
st
loui
mo
unit
state
cholera
toxin
b
ctxb
transferrin
tf
conjug
alexa
fluor
purchas
invitrogen
carlsbad
ca
unit
state
antipprvn
monoclon
antibodi
provid
china
anim
health
epidemiolog
center
qingdao
china
rabbit
polyclon
antipprvh
antibodi
gener
laboratori
specif
antibodi
purchas
santa
cruz
biotechnolog
santa
cruz
ca
unit
state
anticlathrin
monoclon
antibodi
monoclon
antibodi
purchas
abcam
cambridg
unit
state
antibodi
hrpconjug
secondari
antibodi
fitcconjug
antimous
antirabbit
igg
purchas
transgen
biotechnolog
beij
china
tritcphalloidin
purchas
sigma
pool
valid
sirna
target
purchas
santa
cruz
biotechnolog
shrna
target
clathrin
heavychain
chc
shchc
scrambl
rna
kindli
provid
dr
hungjen
liu
institut
molecular
biolog
nation
chung
hsing
univers
taichung
taiwan
briefli
eec
ffc
seed
cell
cultur
plate
contain
fb
densiti
cell
per
well
incub
h
differ
pharmacolog
inhibitor
indic
concentr
ad
incub
h
twenti
microlit
mtt
solut
co
subsequ
ad
incub
h
allow
mtt
fulli
metabol
medium
remov
cell
wash
final
cell
resuspend
formazan
dmso
solut
optic
densiti
read
nm
determin
effect
chemic
inhibitor
viral
entri
postentri
step
cell
treat
differ
inhibitor
h
pprv
inocul
briefli
monolay
eec
ffc
grown
plate
pretreat
respect
inhibitor
indic
concentr
h
cell
viabil
upon
drug
treatment
determin
cell
viabil
assay
cell
inocul
pprv
multipl
infect
moi
h
adsorpt
medium
discard
cell
subsequ
wash
phosphatebuff
salin
pb
cell
cultur
mainten
medium
contain
serum
continu
presenc
inhibitor
dmsotreat
cell
use
control
indic
time
point
cell
collect
western
blot
analysi
prepar
confoc
laser
scan
microscopi
clsm
analysi
wherea
supernat
harvest
viru
titrat
endometri
epitheli
cell
grown
confluenc
cell
cultur
plate
transfect
chc
shrna
plasmid
nm
sirna
use
turbofect
transfect
reagent
thermo
fisher
scientif
cell
incub
optimem
gibco
medium
h
reaction
mixtur
discard
cell
infect
pprv
moi
h
postinfect
hpi
cell
collect
western
blot
analysi
viral
titrat
silenc
effici
quantifi
western
blot
analysi
ultrathin
section
nm
cell
prepar
examin
hitachi
transmiss
electron
microscop
hitachi
high
technolog
co
japan
describ
previous
ishii
et
al
huang
et
al
briefli
pprv
inocul
eec
cultur
cell
factori
system
nunc
day
postinfect
cell
cultur
medium
harvest
subject
three
cycl
freezethaw
centrifug
g
min
subsequ
supernat
centrifug
rpm
min
rotor
beckman
inc
pellet
virion
resuspend
ml
briefli
monolay
eec
infect
pprv
moi
adsorpt
h
sampl
shift
min
min
h
h
cell
collect
centrifug
g
min
subsequ
sampl
prepar
endometri
epitheli
cell
grown
coverslip
confluenc
infect
prrv
moi
indic
time
postinfect
cell
wash
four
time
pb
fix
paraformaldehyd
cell
wash
four
time
pb
treat
triton
min
cell
incub
bovin
serum
albumin
bsa
appropri
primari
antibodi
h
cell
wash
incub
fitc
tritcconjug
secondari
antibodi
actin
filament
stain
tritcphalloidin
min
final
cell
treat
dapi
solut
min
analyz
confoc
microscopi
clsm
leica
germani
addit
imag
record
use
leica
tc
laserscan
confoc
microscop
analyz
imari
softwar
bitplan
visual
manual
segment
surfac
render
investig
endocytosi
eec
incub
alexa
fluor
min
cell
wash
acid
buffer
acet
acid
nacl
ph
min
remov
surfacebound
tf
ctxb
uptak
assay
cell
incub
alexa
fluor
min
wash
pb
cell
fix
paraformaldehyd
final
tf
ctxb
intern
examin
clsm
indic
time
point
cell
lysat
gener
ad
sodium
dodecyl
sulfatepolyacrylamid
gel
electrophoresi
sdspage
sampl
buffer
cell
boil
min
centrifug
protein
sampl
separ
sdspage
gel
transfer
onto
polyvinyliden
difluorid
membran
millipor
billerica
unit
state
membran
block
nonfat
milk
solut
contain
overnight
subsequ
incub
h
primari
antibodi
wash
membran
react
hrpconjug
secondari
antibodi
bound
antibodi
detect
ecl
immunoblot
detect
reagent
millipor
densitometri
analysi
use
imag
softwar
conduct
protein
quantif
collect
cultur
supernat
centrifug
remov
cell
debri
briefli
eec
cultiv
plate
inocul
viru
dilut
prepar
serial
dilut
cell
incub
h
cytopath
effect
cpe
record
viru
titer
calcul
use
method
record
test
perform
triplic
statist
analysi
perform
use
graphpad
prism
version
graphpad
softwar
san
diego
ca
unit
state
softwar
twotail
unpair
student
ttest
use
determin
statist
signific
group
valu
p
consid
indic
statist
signific
wherea
p
consid
indic
highli
signific
differ
data
express
mean
standard
sd
normal
mean
control
group
least
three
independ
experi
investig
pprv
entri
replic
cycl
eec
initi
experi
perform
analyz
uptak
pprv
eec
indic
time
point
use
cslm
shown
figur
viral
particl
intern
distribut
within
boundari
cell
virus
distribut
around
nuclei
time
shown
gradual
intensif
green
fluoresc
signal
specif
pprvn
peak
hpi
moreov
imag
show
pprv
adsorb
onto
cell
surfac
insid
cell
min
pprv
appear
lower
layer
cell
membran
time
pprv
move
insid
eec
hpi
importantli
surfac
render
data
demonstr
pprv
locat
cell
membran
indic
intens
green
signal
imag
furthermor
cell
membran
upper
layer
pprv
success
intern
eec
indic
weak
dark
green
signal
imag
viral
titer
increas
rapidli
hpi
peak
hpi
figur
result
also
show
n
protein
detect
hpi
sharpli
increas
reach
peak
hpi
figur
analysi
clsm
along
n
protein
express
viral
titrat
data
suggest
life
cycl
pprv
h
cultur
host
epitheli
cell
therefor
hpi
consid
optim
time
point
subsequ
experi
determin
viral
protein
express
level
titer
confirm
whether
pprv
entri
eec
ph
depend
detect
effect
two
chemic
inhibitor
chloroquin
cellular
endosom
acidif
inhibitor
silva
et
al
lysosomotrop
weak
base
immedi
rais
ph
acid
vesicl
mizzen
et
al
treatment
mm
chloroquin
treatment
affect
cell
viabil
figur
b
express
level
pprvn
protein
analyz
densitometri
normal
treatment
pprv
addit
significantli
block
entri
replic
pprv
mock
pre
posttreat
sampl
respect
figur
chloroquin
treatment
pprv
addit
also
significantli
inhibit
entri
replic
pprv
mock
pre
posttreat
sampl
respect
figur
viru
titrat
analysi
indic
chloroquinetr
cell
show
inhibit
pprv
entri
replic
figur
similarli
intens
green
fluoresc
signal
specif
pprvn
pprvh
observ
membran
cell
treat
chloroquin
compar
control
cell
figur
therefor
pprv
entri
strongli
inhibit
chloroquinetr
cell
result
demonstr
pprv
infect
requir
low
ph
condit
investig
necessari
uncov
mechan
action
viru
entri
replic
dynamin
requir
mediat
newli
form
vesicl
caveolin
clathrindepend
endocyt
pathway
praefck
mcmahon
determin
effect
dynamin
pprv
infect
dynasor
use
treat
eec
indic
time
period
dynasor
treatment
affect
cell
viabil
figur
howev
dynasor
treatment
pprv
inocul
significantli
inhibit
pprv
infect
eec
mock
pre
posttreat
sampl
respect
figur
viru
titrat
analysi
indic
dynasor
treatment
influenc
pprv
replic
figur
howev
dynasor
treatment
induc
express
green
fluoresc
signal
specif
pprvn
pprvh
protein
cell
membran
observ
control
cell
figur
therefor
pprv
entri
inhibit
dynasoretr
cell
result
suggest
dynamin
critic
pprv
entri
cell
assess
role
clathrin
pprv
entri
eec
cpz
use
specif
block
pathway
wang
et
al
cpz
use
base
cell
viabil
assay
data
figur
clsm
eec
pretreat
cpz
maintain
pprv
infect
transferrin
tf
use
posit
control
clathrinmedi
endocytosi
pathway
shown
figur
red
fluoresc
significantli
reduc
presenc
cpz
confirm
cpz
effect
block
uptak
tf
via
clathrinmed
endocytosi
pathway
wherea
effect
observ
prrvinfect
cell
western
blot
analysi
viral
titrat
assay
perform
eec
treat
cpz
h
either
pprv
inocul
cpz
maintain
infect
express
level
pprvn
protein
analyz
densitometri
normal
less
pronounc
chang
detect
normal
viral
n
protein
express
level
mock
pre
posttreat
sampl
respect
viral
titer
differ
sampl
respect
figur
c
moreov
cpz
treatment
induc
express
green
fluoresc
signal
specif
pprvh
cell
membran
compar
control
cell
figur
find
indic
cpz
treatment
affect
pprv
entri
replic
cell
confirm
role
clathrin
pprv
entri
replic
detect
express
level
chc
pprvn
inhibit
chc
express
shrna
figur
base
western
blot
analysi
express
level
chc
found
significantli
downregul
specif
shchc
compar
scrambl
control
scrambl
shchc
sampl
respect
p
figur
transfect
shchc
prior
pprv
addit
rel
express
level
pprvn
protein
chang
significantli
determin
western
blot
analysi
scrambl
shchc
sampl
respect
figur
viru
titrat
data
scrambl
chc
sirna
sampl
respect
also
support
find
downregul
chc
express
significantli
influenc
pprv
replic
releas
figur
membran
cholesterol
requir
format
caveola
essenti
compon
lipid
raft
deplet
cholesterol
membran
sequestr
cholesterol
nystatin
significantli
block
caveolaemedi
endocytosi
pitha
et
al
sanchezsan
martin
et
al
present
studi
treatment
mm
nystatin
treatment
affect
cell
viabil
figur
f
therefor
concentr
chosen
next
set
experi
cholera
toxin
b
ctxb
use
posit
control
caveolindepend
pathway
shown
figur
treatment
could
effect
block
uptak
ctxb
via
caveolinmedi
endocytosi
pathway
importantli
treatment
also
significantli
inhibit
pprv
intern
figur
western
blot
analysi
show
treatment
viru
addit
significantli
inhibit
entri
replic
pprv
mock
pre
posttreat
sampl
respect
figur
furthermor
nystatin
treatment
viru
addit
significantli
inhibit
viru
entri
howev
nystatin
treatment
viru
addit
affect
pprv
replic
eec
figur
viru
titrat
analysi
indic
treatment
significantli
influenc
pprv
entri
replic
howev
nystatin
treatment
show
impact
pprv
replic
figur
clsm
reveal
nystatin
particular
treatment
induc
green
fluoresc
signal
specif
pprvn
pprvh
cell
membran
evid
control
cell
figur
therefor
pprv
entri
obvious
block
nystatintr
cell
data
indic
pprv
entri
cell
depend
caveola
requir
involv
cholesterol
pprv
virion
pleomorph
shape
vari
size
nm
gibb
et
al
kumar
et
al
present
work
envelop
pprv
particl
nm
initi
observ
attach
eec
surfac
min
post
infect
figur
larger
particl
observ
probabl
due
method
viru
purif
sampl
product
pprv
trigger
plasma
membran
invagin
form
cavelik
structur
wrap
around
bound
virus
min
post
infect
figur
vesicl
travel
cytoplasm
hpi
figur
confirm
role
pprv
entri
replic
detect
express
level
pprvn
inhibit
express
sirna
figur
base
western
blot
analysi
express
level
significantli
downregul
specif
scrambl
sampl
respect
p
figur
treatment
prior
pprv
addit
express
pprvn
protein
significantli
decreas
scrambl
sirna
sampl
respect
figur
viru
titrat
analysi
indic
downregul
express
significantli
impair
pprv
replic
releas
scrambl
sirna
sampl
respect
figur
macropinosom
format
depend
nah
exchang
nhe
eipa
specif
inhibitor
nhe
koivusalo
et
al
mercer
heleniu
investig
whether
pprv
entri
involv
macropinocytosi
pprv
ad
eec
pretreat
dmso
eipa
eipa
treatment
affect
cell
viabil
figur
western
blot
viral
titrat
analysi
demonstr
eipa
treatment
viru
addit
inhibit
entri
replic
pprv
significantli
figur
c
eipa
treatment
induc
express
green
fluoresc
signal
specif
pprvn
pprvh
protein
cell
membran
compar
control
cell
figur
find
indic
eipa
treatment
affect
pprv
entri
replic
therefor
pprv
entri
eec
requir
nhe
addit
report
involv
multipl
stage
macropinocytosi
mercer
heleniu
analyz
whether
pprv
intern
requir
eec
treat
wortmannin
specif
inhibitor
lee
et
al
wortmannin
treatment
affect
cell
viabil
figur
significantli
inhibit
product
infect
pprv
evidenc
prrv
n
express
level
viral
titer
p
except
p
viral
titer
pretreat
cell
figur
c
wortmannin
treatment
obvious
induc
green
fluoresc
signal
specif
pprvn
pprvh
protein
cell
membran
compar
control
cell
figur
indic
wortmannin
treatment
significantli
inhibit
pprv
uptak
collect
data
suggest
pprv
entri
requir
nhe
inhibit
activ
significantli
reduc
pprv
entri
replic
compar
pprv
entri
differ
type
host
cell
first
investig
express
level
receptor
eec
ffc
western
blot
analysi
figur
lower
basal
level
detect
ffc
compar
eec
figur
interestingli
data
show
amount
protein
significantli
increas
eec
ffc
follow
pprv
infect
figur
furthermor
clsm
reveal
significantli
enhanc
stain
cell
surfac
eec
respons
pprv
infect
figur
wherea
pprvinfect
ffc
exhibit
diffus
stain
throughout
entir
cytoplasm
figur
importantli
pharmacolog
inhibit
experi
use
ffc
indic
cpz
eipa
treatment
viru
addit
notic
affect
pprv
n
protein
express
viral
titer
ffc
figur
b
g
j
wherea
treatment
pprv
addit
result
signific
increas
n
protein
express
figur
unlik
result
obtain
eec
chloroquin
nystatin
wortmannin
treatment
prior
pprv
addit
affect
earli
entri
pprv
ffc
howev
treatment
post
pprv
addit
significantli
block
replic
pprv
figur
f
h
contrast
dynasor
treatment
significantli
inhibit
uptak
pprv
replic
viru
ffc
figur
viru
titrat
analysi
indic
treatment
significantli
increas
pprv
infect
figur
j
wherea
dynasor
treatment
significantli
block
pprv
entri
figur
wortmannin
treatment
significantli
block
pprv
replic
figur
cell
viabil
significantli
affect
chemic
inhibitor
ffc
figur
overal
pprv
entri
ffc
may
depend
clathrin
caveolin
low
ph
cholesterol
nhe
howev
dynamin
play
essenti
role
nystatin
wortmannin
treatment
pprv
addit
significantli
inhibit
pprv
replic
pprv
econom
import
pathogen
serious
constrain
product
small
rumin
throughout
world
clinic
ppr
character
high
fever
oculonas
discharg
diarrhea
dyspnea
slough
epithelium
oral
nasal
mucosa
balamurugan
et
al
santhamani
et
al
worth
note
pprv
infect
often
caus
fetal
mummif
abort
late
pregnanc
birth
dead
weak
lamb
die
within
first
day
borel
et
al
abubakar
et
al
howev
pathogenesi
pprv
remain
larg
unknown
predominantli
base
comparison
morbillivirus
show
pprv
success
enter
eec
confirm
pprv
epitheli
tropism
addit
prolifer
pprv
caprin
eec
observ
present
studi
suggest
clinic
phenomenon
abort
pprvinfect
goat
may
attribut
replic
pprv
uteru
thu
provid
theoret
basi
pathogenesi
pprv
anim
virus
util
endocyt
machineri
entri
replic
host
cell
virus
enter
target
cell
endocytosi
easili
pass
plasma
membran
barrier
underli
cortic
matrix
han
et
al
previou
studi
show
paramyxovirus
enter
host
cell
via
membran
fusion
lee
et
al
muhlebach
et
al
howev
newcastl
diseas
viru
may
enter
cell
caveolaemedi
endocytosi
process
depend
acid
ph
cantin
et
al
sanchezfelip
et
al
addit
recent
studi
demonstr
mev
particl
intern
independ
clathrin
caveolin
endocyt
pathway
goncalvescarneiro
et
al
therefor
pathway
via
paramyxovirus
enter
host
cell
like
associ
cell
type
avail
receptor
exampl
sever
studi
shown
slam
play
import
role
facilit
entri
morbillivirus
tatsuo
et
al
baron
goncalvescarneiro
et
al
sever
strain
morbilliviru
shown
use
permiss
receptor
muhlebach
et
al
noyc
et
al
pratakpiriya
et
al
sato
et
al
melia
et
al
interestingli
mev
enter
breast
colon
cancer
cell
macropinocytosi
pathway
delpeut
et
al
therefor
studi
conclud
morbillivirus
enter
target
cell
via
differ
receptor
therebi
trigger
differ
signal
cascad
hashimoto
et
al
fujita
et
al
noyc
et
al
pratakpiriya
et
al
birch
et
al
delpeut
et
al
goncalvescarneiro
et
al
studi
first
show
pprv
could
util
caveolinmedi
endocyt
pathway
enter
epitheli
cell
also
demonstr
acid
ph
dynamin
cholesterol
critic
entri
process
although
morbillivirus
report
enter
cell
manner
increas
number
envelop
virus
report
take
advantag
caveolaemedi
endocytosi
ph
cholesteroldepend
manner
newcastl
diseas
viru
cantin
et
al
tiger
frog
viru
guo
et
al
bk
viru
eash
et
al
previou
studi
demonstr
high
level
express
sheep
epitheli
tissu
taken
mouth
upper
respiratori
tract
stomach
birch
et
al
high
level
express
epitheli
tissu
support
role
protein
pprv
epitheli
pathogenesi
diseas
sheep
goat
often
associ
seriou
patholog
intestin
couacyhymann
et
al
hammouchi
et
al
howev
level
tissu
rel
low
birch
et
al
moreov
although
high
level
express
detect
stomach
patholog
organ
rare
couacyhymann
et
al
hammouchi
et
al
birch
et
al
importantli
pprv
caus
abort
pregnant
sheep
goat
borel
et
al
abubakar
et
al
interestingli
data
found
eec
also
express
receptor
level
goat
correl
well
pprv
infect
vitro
howev
examin
cell
cultur
vitro
may
accur
reflect
situat
vivo
therefor
research
need
area
addit
recent
studi
report
mev
upregul
express
human
murin
brain
endotheli
cell
abdullah
et
al
find
reveal
level
significantli
increas
follow
pprv
infect
eec
ffc
indic
pprv
entri
infect
play
import
role
regul
express
host
epitheli
cell
howev
pprv
infect
induc
express
ffc
data
indic
pprv
may
use
receptor
ffc
probabl
enter
cell
via
differ
rout
previou
studi
shown
virus
actual
util
one
endocyt
pathway
enter
host
cell
sinc
regul
endocytosi
pleiotrop
cell
type
depend
cossart
heleniu
result
also
demonstr
pprv
enter
ffc
dynamindepend
clathrin
caveolaemedi
endocytosi
pathway
indic
requir
pprv
endocytosi
cell
type
specif
overal
show
inhibitor
test
could
complet
block
pprv
entri
replic
suggest
pprv
may
use
one
pathway
entri
differ
cell
ie
cell
fusion
endocyt
pathway
viru
activ
effici
infect
must
first
gain
access
cellular
receptor
may
phdepend
independ
nicola
et
al
zhu
et
al
huang
et
al
intern
paramyxoviru
report
requir
acid
ph
endosom
low
ph
trigger
seri
intracellular
molecular
event
san
roman
et
al
sanchezfelip
et
al
studi
exposur
acid
ph
appear
requir
success
entri
infect
eec
pprv
result
show
pprv
entri
eec
inhibit
elev
ph
intracellular
acid
compart
contrast
ffc
pprv
entri
achiev
primarili
neutral
ph
potenti
result
differ
subsequ
signal
pathway
dynamin
promot
membran
fission
gener
endocyt
vesicl
sever
endocyt
pathway
zhu
et
al
howev
role
dynamin
intern
process
pprv
poorli
understood
studi
result
indic
dynamin
play
essenti
role
caveolaemedi
endocytosi
pprv
eec
although
dynamin
activ
thought
specif
caveola
clathrinmedi
endocytosi
pathway
damk
et
al
data
indic
essenti
role
dynamin
intern
pprv
ffc
effect
independ
clathrin
caveolin
find
also
confirm
essenti
role
dynamin
membran
fusion
damk
et
al
low
low
dynamin
necessari
intern
numer
virus
perri
wobu
guo
et
al
rahn
et
al
addit
membran
cholesterol
compon
lipid
raft
play
import
role
caveolinmedi
endocyt
pathway
riezman
et
al
mercer
heleniu
reorgan
membran
lipid
raft
significantli
inhibit
pprv
intern
multipl
therefor
deplet
cholesterol
treatment
like
rearrang
phosphoinositid
cell
membran
therebi
block
bind
domain
intern
increas
number
virus
found
util
macropinocytosi
pathway
enter
permiss
cell
coyn
et
al
mercer
heleniu
kalin
et
al
de
vri
et
al
delpeut
et
al
present
studi
macropinocytosi
pathway
block
eipa
effici
pprv
infect
decreas
may
indic
macropinocytosi
offer
noninfect
pathway
entri
pprv
host
cell
addit
number
recent
studi
demonstr
virus
may
also
take
advantag
pathway
enter
cell
via
endocyt
pathway
mercer
heleniu
sanchez
et
al
present
data
show
block
activ
inhibit
pprv
initi
entri
also
arrest
viral
replic
result
suggest
may
regul
caveolinmedi
endocyt
pathway
trigger
complex
signal
pathway
wortmannin
also
report
inhibit
member
pololik
kinas
famili
liu
et
al
highli
select
inhibitor
kinas
mtor
atr
catalyt
subunit
dnadepend
protein
kinas
brunn
et
al
wymann
et
al
walker
et
al
data
impli
close
correl
pprv
variou
kinas
although
precis
mechan
remain
elucid
moreov
recent
studi
indic
pprv
exploit
cellular
autophagi
machineri
replic
richetta
et
al
zhang
et
al
inhibit
activ
may
inhibit
earli
autophagi
therebi
reduc
viru
entri
replic
present
studi
provid
systemat
model
identifi
entri
mechan
pprv
host
cell
data
reveal
pprv
enter
eec
cholesterol
ph
dynamindepend
manner
via
caveolaemedi
endocytosi
pathway
accompani
regul
demonstr
viral
cellular
compon
involv
pprv
entri
host
cell
combin
underli
mechan
govern
process
provid
insight
new
antivir
therapeut
strategi
work
might
contribut
develop
novel
method
control
prevent
spread
pprv
paramyxovirus
carri
experi
collect
data
wrote
manuscript
xq
check
revis
manuscript
hg
pj
sc
zc
tw
particip
experi
jw
qx
conceiv
studi
particip
design
coordin
author
discuss
result
comment
manuscript
approv
final
version
author
declar
research
conduct
absenc
commerci
financi
relationship
could
constru
potenti
conflict
interest
